STERIS plc (NYSE:STE) Stock Holdings Increased by GHP Investment Advisors Inc.

GHP Investment Advisors Inc. grew its holdings in shares of STERIS plc (NYSE:STE - Free Report) by 5.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 59,298 shares of the medical equipment provider's stock after acquiring an additional 3,213 shares during the period. GHP Investment Advisors Inc. owned about 0.06% of STERIS worth $12,189,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of STE. Bleakley Financial Group LLC grew its stake in STERIS by 8.7% during the 3rd quarter. Bleakley Financial Group LLC now owns 1,680 shares of the medical equipment provider's stock valued at $407,000 after purchasing an additional 134 shares in the last quarter. Franklin Resources Inc. grew its position in shares of STERIS by 171.2% during the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider's stock worth $191,370,000 after buying an additional 529,308 shares in the last quarter. Assetmark Inc. increased its stake in shares of STERIS by 24.6% in the third quarter. Assetmark Inc. now owns 13,410 shares of the medical equipment provider's stock worth $3,252,000 after buying an additional 2,647 shares during the last quarter. KBC Group NV raised its holdings in STERIS by 52.0% in the third quarter. KBC Group NV now owns 12,071 shares of the medical equipment provider's stock valued at $2,928,000 after acquiring an additional 4,132 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new position in STERIS during the 3rd quarter valued at $9,949,000. 94.69% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at STERIS

In other news, SVP Cary L. Majors sold 1,682 shares of the business's stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $217.32, for a total transaction of $365,532.24. Following the completion of the transaction, the senior vice president now directly owns 11,372 shares in the company, valued at approximately $2,471,363.04. The trade was a 12.88 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 1.14% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on STE shares. JMP Securities reissued a "market outperform" rating and issued a $265.00 target price on shares of STERIS in a research report on Thursday. Stephens reissued an "overweight" rating and issued a $240.00 price objective on shares of STERIS in a report on Thursday. Needham & Company LLC reaffirmed a "hold" rating on shares of STERIS in a report on Friday, November 8th. Piper Sandler lifted their target price on STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research report on Monday, February 3rd. Finally, StockNews.com lowered STERIS from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, October 29th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $258.75.

STERIS Stock Performance

STE stock traded up $0.93 during midday trading on Monday, reaching $224.16. The company had a trading volume of 430,075 shares, compared to its average volume of 508,272. The firm has a market capitalization of $22.13 billion, a PE ratio of 47.59 and a beta of 0.84. The stock has a 50 day moving average price of $212.57 and a 200 day moving average price of $224.46. STERIS plc has a fifty-two week low of $197.82 and a fifty-two week high of $248.24. The company has a quick ratio of 1.55, a current ratio of 2.13 and a debt-to-equity ratio of 0.32.

STERIS (NYSE:STE - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Analysts anticipate that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be given a $0.57 dividend. The ex-dividend date is Thursday, February 20th. This represents a $2.28 annualized dividend and a yield of 1.02%. STERIS's dividend payout ratio is presently 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.